• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Pulmonary Embolism and Pulmonary Hypertension

July 4, 2015 By Dr. Jeremy Feldman

It is important to assess the right ventricle of the heart of PH patients

A recent reader of PulmonaryHypertensionRN.com wrote in with an excellent question that I suspect is on many patients minds.  Pulmonary embolism (a blood clot in your lung) is a very common medical problem.  Occasionally this can lead to pulmonary hypertension in a few percent of patients.  The larger the blood clot the greater the likelihood that if you had an echocardiogram shortly after the event you would have signs of mild pulmonary hypertension.  What is the appropriate management and follow up?

Blood Thinners for Pulmonary Embolism

The majority of patients with pulmonary embolism can be managed with blood thinners such as Heparin, Lovenox, Xarelto, Eliquis or Warfarin.  Over time, blood thinners prevent further blood clots and allow your body to dissolve the existing blood clot.  More than 95% of patients will do very well with blood thinners and their symptoms should resolve within a few weeks to a couple of months.  By three months, the majority of patients have had maximal resolution of their blood clots.

The duration of anticoagulation (use of blood thinners) depends on the circumstances surrounding your blood clot. Was it provoked? Or was it unprovoked by external circumstances such as surgery, trauma or hospitalization?

In patients that had evidence of elevated pulmonary artery pressure by echocardiography, we would favor repeating an echo about 3 months after the initial event.  This time interval allows your body to dissolve the blood clot with help from blood thinners.  If you have ongoing evidence of pulmonary hypertension at the three-month mark, you should see a specialist with expertise in the evaluation and management of pulmonary hypertension.  If your echocardiogram is reassuring, no further testing is required.

Filed Under: Living with PAH

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

Internal anatomy of the pulmonary arteries

Do I or Don’t I Have PAH?

By Dr. Jeremy Feldman

We had a wonderful topic suggestion from a reader. Essentially, how does one tell if they have Pulmonary Arterial

pulmonary hypertension research laboratory

C76 Approved For Studies in Pulmonary Hypertension

By Dr. Jeremy Feldman

Pulmonary arterial hypertension at its core is a disease of abnormal lung blood vessel behavior. While our currently

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives